A metabolite of Daranavir (D193500). It is a COVID19-related research product.
References
[1] MARC VERMEIR. Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects.[J]. Drug Metabolism and Disposition, 2009, 37 1: 809-820. DOI: 10.1124/dmd.108.024109
